Research
Mixed
In patients with cirrhosis, sarcopenia is driven by a multifactorial imbalance between protein synthesis and breakdown, specifically involving hyperammonemia, increased autophagy, and impaired mitochondrial function, rather than just caloric deficit.
For cirrhosis patients, muscle loss is a complex biological failure, not just a diet problem. Treatment requires addressing the root causes like ammonia levels and inflammation, not just increasing calories.
GoodSupportsHIGH confidence
The pathogenesis of sarcopenia is multifactorial and results from an imbalance between protein synthesis and breakdown. Hyperammonemia, increased autophagy, proteasomal activity, lower protein synthesis, and impaired mitochondrial function play an important role in muscle depletion in cirrhosis.
Why this rating
Based on a comprehensive review of clinical and animal studies, though direct causal links in humans are noted as 'scare'.
Source
Sarcopenia in cirrhosis: from pathogenesis to interventions
Maryam Ebadi et al. · Journal of Gastroenterology · 2019
DOI 10.1007/s00535-019-01605-6
narrative_reviewCited 291×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Moderate exercise combined with appropriate energy and protein intake is a necessary intervention to reverse sarcopenia in cirrhosis, potentially alongside pharmacological agents like BCAAs or testosterone.Moderate
- Branched-chain amino acid (BCAA) supplementation (0.45 g/kg or 12g/day) can improve ammonia metabolism and nitrogen balance in cirrhosis patients, though single doses may transiently raise blood ammonia.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →